Literature DB >> 20579802

Raman spectroscopy: a novel experimental approach to evaluating renal tumours.

Karim Bensalah1, Julien Fleureau, Denis Rolland, Olivier Lavastre, Nathalie Rioux-Leclercq, François Guillé, Jean-Jacques Patard, Lotfi Senhadji, Renaud de Crevoisier.   

Abstract

BACKGROUND: New optical techniques of spectroscopy have shown promising results in the evaluation of solid tumours.
OBJECTIVE: To evaluate the potential of Raman spectroscopy (RS) to assess renal tumours at surgery. DESIGN, SETTING, AND PARTICIPANTS: Over a 5-mo period, Raman optical spectra were prospectively acquired on surgical renal specimens removed due to suspicion of cancer. MEASUREMENTS: Raman measures were normalised to ensure comparison between spectra. A lower resolution signal was computed using a wavelet decomposition procedure to diminish the size of the signal and exploit the complete spectrum. A support vector machine (SVM) with a linear kernel and a sequential minimal optimisation solver was applied. A leave-one-out cross-validation technique was used to train and test the SVM. RESULTS AND LIMITATIONS: There were 36 patients with 34 malignant tumours (27 clear-cell, 6 papillary, and 1 chromophobe) and 2 benign (1 oncocytoma and 1 metanephric cyst) tumours. A total of 241 analysable Raman spectra were obtained. The SVM was able to classify tumoural and normal tissue with an accuracy of 84% (sensitivity 82%, specificity 87%). High-grade and low-grade tumours were differentiated with a precision of 82% (sensitivity 84%, specificity 80%). Histologic subtype could be categorised with an accuracy of 93% (sensitivity 96%, specificity 87%). SVM could not be applied to classify benign and malignant tumours because of the restricted number of benign spectra.
CONCLUSIONS: RS can accurately differentiate normal and tumoural renal tissue, low-grade and high-grade renal tumours, and histologic subtype of renal cell carcinoma. Larger prospective studies are needed to confirm these preliminary data. Copyright 2010 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20579802     DOI: 10.1016/j.eururo.2010.06.002

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  8 in total

Review 1.  Treatment approaches to small renal masses in patients of advanced age (≥75 years).

Authors:  Muhammet Fuat Özcan; Serkan Altınova; Ali Atan
Journal:  Turk J Urol       Date:  2018-07

Review 2.  Label-free molecular imaging of the kidney.

Authors:  Boone M Prentice; Richard M Caprioli; Vincent Vuiblet
Journal:  Kidney Int       Date:  2017-07-24       Impact factor: 10.612

3.  [Application of Raman-based technologies in the detection of urological tumors].

Authors:  Z Hao; S H Yue; L Q Zhou
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-08-18

4.  Raman microspectroscopy as a biomarking tool for in vitro diagnosis of cancer: a feasibility study.

Authors:  Aleksandra Pavićević; Sofija Glumac; Jelena Sopta; Ana Popović-Bijelić; Milos Mojović; Goran Bacić
Journal:  Croat Med J       Date:  2012-12       Impact factor: 1.351

5.  Renal mass biopsy using Raman spectroscopy identifies malignant and benign renal tumors: potential for pre-operative diagnosis.

Authors:  Yufei Liu; Zhebin Du; Jin Zhang; Haowen Jiang
Journal:  Oncotarget       Date:  2017-05-30

6.  Automated Computational Detection of Disease Activity in ANCA-Associated Glomerulonephritis Using Raman Spectroscopy: A Pilot Study.

Authors:  Adam D Morris; Daniel L D Freitas; Kássio M G Lima; Lauren Floyd; Mark E Brady; Ajay P Dhaygude; Anthony W Rowbottom; Francis L Martin
Journal:  Molecules       Date:  2022-04-02       Impact factor: 4.411

Review 7.  Clinical and investigative applications of Raman spectroscopy in Urology and Andrology.

Authors:  E Charles Osterberg; Melissa A Laudano; Philip S Li
Journal:  Transl Androl Urol       Date:  2014-03

8.  Efficacy of raman spectroscopy in the diagnosis of kidney cancer: A systematic review and meta-analysis.

Authors:  Hongyu Jin; Xiao He; Hui Zhou; Man Zhang; Qingqing Tang; Lede Lin; Jianqi Hao; Rui Zeng
Journal:  Medicine (Baltimore)       Date:  2020-07-02       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.